Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence.

References

• Breslow L: Prevention and control of noncommunicable diseases. World Health Forum 3: 429–431, 1982.
   Google Scholar
• Editorial: Mass strategies of prevention; the swings and roundabouts. Lancet 2: 1256–1257, 1982.
   Google Scholar
• Zimmet PZ: Primary prevention of diabetes mellitus. Diabetes Care 11: 258–262, 1988.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Lieberman S, Gondal J: Macronutrients in hypertension. J Am Coll Nutr 15: 22–33, 1996.
   Google Scholar
• Tuomilehto J, Zimmet P, Taylor R, Bennett P, Kankaanapaa J, Wolfe E: A cross sectional ecological analysis of blood pressure and its determinants in eleven Pacific populations. J Am Coll Nutr 8: 151–165, 1989.
   PubMed Web of Science ®Google Scholar
• Lindahl O, Lindwall L, Spangberg A, Stenram A, Uckerman PA: A vegans regimen with reduced medication in the treatment of hypertension. Br J Nutr 52: 11–20, 1984.
   PubMed Web of Science ®Google Scholar
• Szanto S, Yudkin J: The effects of dietary sucrose on blood lipids, serum insulin, platelet adhesivesness and body weight in human volunteers. Postgrad Med J 45: 602–607, 1969.
   PubMed Web of Science ®Google Scholar
• Reaven GM: Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 90(Suppl):7S–12S, 1991.
   Google Scholar
• Reaven GM, Ho H, Hoffman BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 12: 129–132, 1988.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Ho H, Hoffman BB: Somatostatin inhibition of fructose-induced hypertension. Hypertension 14: 117–120, 1989.
   PubMed Web of Science ®Google Scholar
• Landin K, Tengborn L, Smith U: Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Int Med 229: 181–187, 1991.
   PubMed Web of Science ®Google Scholar
• Lee M-K, Miles PDG, Khoursheed M, Gao K-M, Moosa AR, Olefsky JM: Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43: 1435–1439, 1994.
   PubMed Web of Science ®Google Scholar
• Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331: 1188–1193, 1994.
   PubMed Web of Science ®Google Scholar
• Garcia MJ, McNamara RM, Gordon T, Kannell WB: Morbidity and mortality in diabetics in the Framingham population. Diabetes 3: 105–111, 1974.
   Google Scholar
• Klein BE, Kline R, Moss SE: Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Public Health 74: 336–339, 1984.
   PubMed Web of Science ®Google Scholar
• Monolio TA, Savage PJ, Burke GL, Liu KL, Wagenknecht LE, Sidney S, Jacobs DR, Roseman JM, Donahue RP, Oberman A: Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 10: 430–436, 1990.
   PubMedGoogle Scholar
• Kriger DR, Landsberg L: Mechanisms in obesity-related hypertension: role of insulin and catecholamines Am J Hypertens 1: 84–90, 1988.
   PubMedGoogle Scholar
• Masoro EJ, McCarter RJM, Katz MS, McMahan CA: Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47: B202–B208, 1992.
   PubMedGoogle Scholar
• Cerami A, Vlassare H, Brownlee M: Glucose and aging. Sci Am 256: 90–96, 1987.
   PubMed Web of Science ®Google Scholar
• Reaven GM: Role of insulin resistance in human disease (banting Lecture 1988). Diabetes 37: 1595–1607, 1988.
   PubMed Web of Science ®Google Scholar
• Makita Z, Radoff S, Ray field EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836–842, 1991.
   PubMed Web of Science ®Google Scholar
• Parfey PS, Harnett JD: Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol 23: 311–330, 1994.
   PubMedGoogle Scholar
• DeFronzo R: Glucose intolerance and aging. Diabetes Care 4: 493–501, 1981.
   PubMed Web of Science ®Google Scholar
• Fink RI, Kolterman OG, Griffin J, Olefsky JM: Mechanisms of insulin resistance in aging. J Clin Invest 71: 1523–1535, 1983.
   PubMed Web of Science ®Google Scholar
• Chen M, Bergman RN, Porte Jr D: Insulin resistance and B-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 67: 951–957, 1988.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Chen N, Hollenbeck C, Chen YDI: Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Geriatr Soc 37: 735–740, 1989.
   PubMed Web of Science ®Google Scholar
• Broughton DL, Taylor RL: Review: deterioration of glucose tolerance with age: The role of insulin resistance. Age and Aging 20: 221–225, 1991.
   PubMed Web of Science ®Google Scholar
• Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R: Age as independent determinant of glucose tolerance. Diabetes 40: 44–51, 1991.
   PubMed Web of Science ®Google Scholar
• Dengel DR, Pratley RE, Hagberg JM, Goldberg AP: Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension 23: 320–324, 1994.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferinimmi E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194, 1991.
   PubMed Web of Science ®Google Scholar
• Reiser KM: Nonenzymatic glycation of collagen in aging and diabetes. Proceedings of the Society for Experimental Biology and Medicine 33: 626–634, 1985.
   Google Scholar
• Cerami A: Hypothesis. Glucose as a mediator of aging. J Am Geriatr Soc 33: 626–634, 1985.
   PubMed Web of Science ®Google Scholar
• Spencer RP: Life prolongation with dietary restriction: protection of genome and core metabolism and the role of glycosylation. Med Hypoth 40: 102–104, 1993.
   PubMedGoogle Scholar
• Gallaher DD, Csallany AS, Shoeman DW, Olson JM: Diabetes increases excretion of urinary malonaldehyde conjugates in rats. Lipids 28: 663–666, 1993.
   PubMed Web of Science ®Google Scholar
• Flack JM, Showers JR. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 91(Suppl IA):11S-21S, 1991.
   PubMedGoogle Scholar
• Nafziger AN, Herrington DM, Bush TL: Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease. Epidemiol Rev 13: 267–293, 1991.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Clore JN, Blackard WG: Dehydroepiandrosterone: the “missing link” between hyperinsulinemia and atherosclerosis? FASEB J 6: 3073–3075, 1992.
   PubMedGoogle Scholar
• Harman D: Free-radical theory of aging. Ann NY Acad Sciences. 717: 1–15, 1994.
   PubMed Web of Science ®Google Scholar
• Cutler RG: Antioxidants and aging. Am J Clin Nutr 53: 373S–379S, 1991.
   PubMed Web of Science ®Google Scholar
• Harman D: Role of antioxidant nutrients in aging: overview. Age 18: 51–62, 1995.
   Google Scholar
• Kehrer JP: Free radicals as mediators of tissue injury and disease. Critical Rev Toxicol 23: 21–48, 1993.
   PubMed Web of Science ®Google Scholar
• Haliwell B, Cross CE: Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102(Suppl 10):5–12, 1994.
   Google Scholar
• Aureoma OI: Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32: 671–683, 1994.
   PubMedGoogle Scholar
• Stohs SJ: The role of free radicals in toxicity and disease. Free Radicals 6: 1–24, 1995.
   Google Scholar
• Jacques PF: A cross sectional study of Vitamin C intake and blood pressure in the elderly. Int J Vit Nutr Res 62: 252–255, 1992.
   PubMedGoogle Scholar
• Yoshioka M, Matsushita T, Churman Y: Inverse association of serum ascorbic acid level and blood pressure on rate of hypertension in male adults aged 30–39 years. Int J Vitam Nutr Res 54: 343–347.
   PubMedGoogle Scholar
• Solonen JT, Solonen R, Ihanainen M, Parwiainen M, Sepparnen R, Kantola M, Seppanen K, Rauramaa R: Blood pressure, dietarry fats, and antioxidants. Am J Clin Nutr 48: 1226–1232, 1988.
   PubMedGoogle Scholar
• McCarron DA, Morris CD, Henryk HJ, Stantton JL: Blood pressure and nutrient intake in the United States. Science 224: 13392–1398, 1984.
   Google Scholar
• Choi ESK, Jacques PF, Dallal GE, Jacobs RA: Correlation of blood pressure with plasma ascorbic acid. Nutr Res 11: 1377–1382, 1991.
   Web of Science ®Google Scholar
• Cohen L, Feldman EB, Feldman DS, Hames CG: Dietary antioxidants and blood pressure. (Abstract). Am J Clin Nutr 51: 512, 1990.
   Web of Science ®Google Scholar
• Jacques PF: A cross-sectional study of Vitamin C intake and blood pressure in the elderly. Int J Vitam Nutr Res 62: 252–255, 1992.
   PubMedGoogle Scholar
• Efstratopoulos AD, Voyaki SM: Effects of antioxidants on acute blood pressure response to smoking in normotensives and hypertensives. J Hypertens 11(suppl 5):S112-S113, 1993.
   Google Scholar
• Oster O, Prellwitz W: Selenium and cardiovascular disease. Biol Trace Elem Res 24: 91–103, 1990.
   PubMed Web of Science ®Google Scholar
• Salonen JT: Dietary fats, antioxidants, and blood pressure. Ann Med 23: 295–298, 1991.
   PubMed Web of Science ®Google Scholar
• Greenburg S, Frishman WH: Co-enzyme Q10: A new drug for cardiovascular disease. J Clin Pharmacol 30: 596–608, 1990.
   PubMedGoogle Scholar
• Maxwell SRJ: Prospects for the use of antioxidant therapy. Drugs 49: 345–361, 1995.
   PubMed Web of Science ®Google Scholar
• Masoro EJ: Assessment of nutritional components in prolongation of life and health by diet. Proc Soc Exper Biol Med 193: 31–34, 1990.
   PubMed Web of Science ®Google Scholar
• Hopkin K: Aging in focus: caloric restriction may put brakes on aging. J Natl Instit Health 7: 47–50, 1995.
   Google Scholar
• Coleman GL, Barthold SW, Osbaldiston GW, Foster SJ, Jonas AM: Pathological changes during aging in barrier-reared Fischer 344 male rats. J Gerontol 32: 258–278, 1977.
   PubMedGoogle Scholar
• Bertrand HA, Lynd FT, Masoro EJ, Yu BP: Changes in adipose mass and cellularity through the adult life of rats fed ad libitum a life-prolonging restricted diet. J Gerontol 35: 827–835, 1980.
   PubMedGoogle Scholar
• Yu BP, Masoro EJ, Murata I, Bertrand HA, Lynd FT: Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass, and disease. J Gerontol 37: 130–141, 1982.
   PubMedGoogle Scholar
• Yu BP, Masoro EJ, McMahan CA: Nutritional influences on aging of Fischer 344 rats: I. physical, metabolic, and longevity cahracteristics. J Gerontol 40: 657–670, 1985.
   PubMedGoogle Scholar
• Maeda H, Gleiser CA, Masoro EJ, Murata I, McMahan CA, Yu BP: Nutritional influences on aging of Fischer 344 rats: II. pathology. J Gerontol 40: 671–688, 1985.
   PubMedGoogle Scholar
• Iwasaki K, Gleiser CA, Masoro EJ, McMahaan CA, Seo EJ, Yu BP: The influence of dietary protein source on longevity of age-related disease processes of Fischer rats. J Gerontol 43: B5–B12, 1988.
   PubMedGoogle Scholar
• Masoro EJ, Iwasaki K, Gleiser CA, McMahon CA, Seo EJ, Yu BP: Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr 49: 1217–1227, 1989.
   PubMed Web of Science ®Google Scholar
• Cahan V: New study of caloric restricted rodents shows dramatic reduction of disease and increased life span. NIA Announcement Sept 30, pp 5–7, 1991.
   Google Scholar
• McCarty MF: Homologous physiological effects of phenformin and chromium picolinate. Med Hypoth 41: 316–334, 1993.
   PubMed Web of Science ®Google Scholar
• Evans GW, Meyer LK: Life span is increased in rats supplemented with a chromium-pyridine 2 carboxylate complex. Adv Sci Res 1: 19–23, 1994.
   Google Scholar
• Ledvina M, Hodanova M: The effect of simultaneous administration of tocopherol and sunflower oil on the life-span of female mice. Exp Gerontol 15: 67–71, 1980.
   PubMedGoogle Scholar
• Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ: Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci 81: 739–742, 1991.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Quatraro A, Caretta F, Varano R, Giugliano D: Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin dependent diabetes. Diabetes Metabol 16: 318–322, 1990.
   Google Scholar
• Ferrannini E, Bussigoli G, Bonadonna R, et al.: Insulin resistance in essential hypertension. N Engl J Med 317: 350–357, 1987.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Hoffman BB: A role for insulin in the aetiology and course of hypertension? Lancet ii: 435–436, 1987.
   Google Scholar
• Fuh MM-T, Shieh S-M, Wu D-A, Chen Y-DI, Reaven GM: Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 147: 1035–1038, 1987.
   PubMed Web of Science ®Google Scholar
• Iimura O, Shimamoto K, Matsuda K, et al.: Effects of angiotenssin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 8: 353–357, 1995.
   PubMed Web of Science ®Google Scholar
• Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM: Blood pressure, insulin, and glycemia in nondiabctic subjects. Am J Med 80: 861–864, 1983.
   Google Scholar
• Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG: Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Mechanisms and implications for management. JAMA 247: 49–52, 1982.
   PubMedGoogle Scholar
• Sims EAH, Berchtold P: Obesity and hypertension. Mechanisms and implications for management. JAMA 247: 49–52, 1982.
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Mandroukas K, Sjostrom L, Sullivan L, Wetterquist H, Bjomtorp PI: Effects of long-term physical training on body fat, metabolism and blood pressure in obesity. Metabolism 28: 650–658, 1979.
   PubMed Web of Science ®Google Scholar
• Yudkin J: Sucrose, coronary heart disease, diabetes, and obesity: do hormones provide a link? Am Heart J 115: 493–498, 1988.
   PubMed Web of Science ®Google Scholar
• Sower JR: Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy. Am Heart J 122: 932–935, 1991.
   PubMed Web of Science ®Google Scholar
• Evans GW, Swensen G, Walters K: Chromium picolinate decreases calcium excretion and increases dehydroepiandrosterone (DHEA) in post menopausal women. FASEB J 9: A449, 1995.
   Google Scholar
• Nafziger AN, Herrington DM, Bush TL: Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease. Epidemiol 13: 267–293, 1991.
   Google Scholar
• Nestler JE, Beer NA, Jakubowicz J, Beer RM: Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab 78: 549–554, 1994.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Clore JN, Strauss JF 3rd: The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and Cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64: 180–184, 1987.
   PubMed Web of Science ®Google Scholar
• Buffington CK, Pourmotabbed G, Kitabchi AE: Case report: amelioration of insulin resistance in diabetes with dehydroepiandosterone. Am J Med Sci 306: 320–324, 1993.
   PubMedGoogle Scholar
• Merz W: Chromium occurrence and function in biological systems. Physiol Rev 49: 165–239, 1969.
   Google Scholar
• Barrett-connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315: 1519–1524, 1986.
   PubMed Web of Science ®Google Scholar
• Reid IR, Evans MC, Cooper GJS, Ames RW, Stapleton J: Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 265: E655–E659, 1993.
   PubMed Web of Science ®Google Scholar
• Buysschaaert M, Cauwe F, Jamaart J: Proximal femur density in type 1 and 2 diabetic patients. Diabetes Metabol 18: 32–37, 1992.
   Google Scholar